Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Identification of Chromosomal Regions Linked to Diabetic Nephropathy: A Meta-Analysis of Genome-Wide Linkage Scans.

Tziastoudi M, Stefanidis I, Stravodimos K, Zintzaras E.

Genet Test Mol Biomarkers. 2019 Feb;23(2):105-117. doi: 10.1089/gtmb.2018.0209. Epub 2019 Jan 29.

PMID:
30694714
2.

The lysine-specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer.

Rampias T, Karagiannis D, Avgeris M, Polyzos A, Kokkalis A, Kanaki Z, Kousidou E, Tzetis M, Kanavakis E, Stravodimos K, Manola KN, Pantelias GE, Scorilas A, Klinakis A.

EMBO Rep. 2019 Jan 21. pii: e46821. doi: 10.15252/embr.201846821. [Epub ahead of print]

PMID:
30665945
3.

Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece--the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG).

Tsironis G, Koutsoukos K, Athanasakis K, Tsiara A, Tzannis K, Gerolympou M, Visvikis A, Oikonomopoulos G, Kollia A, Giannopoulou E, Dimitra M, Kostouros E, Papatsoris A, Dellis A, Stravodimos K, Varkarakis I, Samantas E, Aravantinos G, Kentepozidis N, Christodoulou C, Bozionelou V, Dimopoulos MA, Bamias A.

Expert Rev Pharmacoecon Outcomes Res. 2018 Nov 10:1-11. doi: 10.1080/14737167.2019.1546121. [Epub ahead of print]

PMID:
30417707
4.

Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients.

Avgeris M, Tsilimantou A, Levis PK, Tokas T, Sideris DC, Stravodimos K, Ardavanis A, Scorilas A.

Br J Cancer. 2018 Dec;119(12):1477-1486. doi: 10.1038/s41416-018-0320-6. Epub 2018 Oct 30.

PMID:
30374124
5.

Combined robot assisted right partial nephrectomy and cholecystectomy with single docking.

Stravodimos K, Katafigiotis I, Pournaras C, Dimitroulis D, Kousournas G, Fragkiadis E, Constantinides C.

J Robot Surg. 2018 Mar 29. doi: 10.1007/s11701-018-0805-6. [Epub ahead of print]

PMID:
29600421
6.

miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression.

Tsikrika FD, Avgeris M, Levis PK, Tokas T, Stravodimos K, Scorilas A.

Genes Chromosomes Cancer. 2018 Mar;57(3):150-161. doi: 10.1002/gcc.22516. Epub 2017 Dec 15.

PMID:
29181884
7.

Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.

Latosinska A, Mokou M, Makridakis M, Mullen W, Zoidakis J, Lygirou V, Frantzi M, Katafigiotis I, Stravodimos K, Hupe MC, Dobrzynski M, Kolch W, Merseburger AS, Mischak H, Roubelakis MG, Vlahou A.

Oncotarget. 2017 Apr 20;8(41):69435-69455. doi: 10.18632/oncotarget.17279. eCollection 2017 Sep 19.

8.

Bladder cancer to patients younger than 30 years: a retrospective study and review of the literature.

Katafigiotis I, Sfoungaristos S, Martini A, Stravodimos K, Anastasiou I, Mykoniatis I, Duvdevani M, Constantinides C.

Urologia. 2017 Oct 25;84(4):231-235. doi: 10.5301/uj.5000264. Epub 2017 Sep 5. Review.

PMID:
28885656
9.

A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy.

Tziastoudi M, Stefanidis I, Hadjigeorgiou GM, Stravodimos K, Zintzaras E.

Clin Kidney J. 2017 Jun;10(3):293-300. doi: 10.1093/ckj/sfx008. Epub 2017 Apr 6.

10.

Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation.

Bamias A, Escudier B, Sternberg CN, Zagouri F, Dellis A, Djavan B, Tzannis K, Kontovinis L, Stravodimos K, Papatsoris A, Mitropoulos D, Deliveliotis C, Dimopoulos MA, Constantinides CA.

Oncologist. 2017 Jun;22(6):667-679. doi: 10.1634/theoncologist.2016-0435. Epub 2017 Jun 7. Review.

11.

Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer.

Alevizopoulos A, Tyritzis S, Leotsakos I, Anastasopoulou I, Pournaras C, Kotsis P, Katsarou O, Alamanis C, Stravodimos K, Constantinides C.

Int J Urol. 2017 Feb;24(2):130-136. doi: 10.1111/iju.13271. Epub 2016 Dec 22.

12.

Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis.

Tokas T, Avgeris M, Alamanis C, Scorilas A, Stravodimos KG, Constantinides CA.

J Cancer Res Clin Oncol. 2017 Mar;143(3):521-532. doi: 10.1007/s00432-016-2301-6. Epub 2016 Nov 17.

PMID:
27858162
13.

In the search of novel urine biomarkers for the early diagnosis of prostate cancer. Intracellular or secreted proteins as the target group? Where and how to search for possible biomarkers useful in the everyday clinical practice.

Katafigioti A, Katafigiotis I, Sfoungaristos S, Alamanis C, Stravodimos K, Anastasiou I, Roumelioti E, Duvdevani M, Constantinides C.

Arch Ital Urol Androl. 2016 Oct 5;88(3):195-200. doi: 10.4081/aiua.2016.3.195.

14.

Primary Adenocarcinoma of the Seminal Vesicles: A Very Rare Neoplasia Occurring in a 56-Year-Old Patient.

Katafigiotis I, Mitsos P, Kousournas G, Sfoungaristos S, Stravodimos K, Anastasiou I, Duvdevani M, Sakellariou S, Korkolopoulou P, Constantinides CA.

Clin Genitourin Cancer. 2017 Feb;15(1):e127-e129. doi: 10.1016/j.clgc.2016.06.015. Epub 2016 Jun 29. No abstract available.

PMID:
27460553
15.

Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients.

Liontos M, Trigka EA, Korkolopoulou P, Tzannis K, Lainakis G, Koutsoukos K, Kostouros E, Lykka M, Papandreou CN, Karavasilis V, Christodoulou C, Papatsoris A, Skolarikos A, Varkarakis I, Adamakis I, Alamanis C, Stravodimos K, Mitropoulos D, Deliveliotis C, Constantinidis CA, Saetta A, Patsouris E, Dimopoulos MΑ, Bamias A.

World J Urol. 2017 Mar;35(3):411-419. doi: 10.1007/s00345-016-1890-7. Epub 2016 Jul 9.

PMID:
27395374
16.

Primary Malignant Melanoma of Renal Pelvis with Extensive Clear Cell Change.

Liapis G, Sarlanis H, Poulaki E, Stravodimos K, Riccioni O, Lazaris AC.

Cureus. 2016 Apr 21;8(4):e583. doi: 10.7759/cureus.583.

17.

Primary adenocarcinoma of the seminal vesicles. A review of the literature.

Katafigiotis I, Sfoungaristos S, Duvdevani M, Mitsos P, Roumelioti E, Stravodimos K, Anastasiou I, Constantinides CA.

Arch Ital Urol Androl. 2016 Mar 31;88(1):47-51. doi: 10.4081/aiua.2016.1.47. Review.

18.

Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study.

Frantzi M, van Kessel KE, Zwarthoff EC, Marquez M, Rava M, Malats N, Merseburger AS, Katafigiotis I, Stravodimos K, Mullen W, Zoidakis J, Makridakis M, Pejchinovski M, Critselis E, Lichtinghagen R, Brand K, Dakna M, Roubelakis MG, Theodorescu D, Vlahou A, Mischak H, Anagnou NP.

Clin Cancer Res. 2016 Aug 15;22(16):4077-86. doi: 10.1158/1078-0432.CCR-15-2715. Epub 2016 Mar 29.

19.

Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysis.

Bamias A, Tsantoulis P, Zilli T, Papatsoris A, Caparrotti F, Kyratsas C, Tzannis K, Stravodimos K, Chrisofos M, Wirth GJ, Skolarikos A, Mitropoulos D, Constantinides CA, Deliveliotis C, Iselin CE, Miralbell R, Dietrich PY, Dimopoulos MA.

Cancer Med. 2016 Jun;5(6):1098-107. doi: 10.1002/cam4.685. Epub 2016 Mar 22.

20.

Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation.

Chatziharalambous D, Lygirou V, Latosinska A, Stravodimos K, Vlahou A, Jankowski V, Zoidakis J.

PLoS One. 2016 Feb 18;11(2):e0149471. doi: 10.1371/journal.pone.0149471. eCollection 2016.

21.

Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG).

Bamias A, Peroukidis S, Stamatopoulou S, Tzannis K, Koutsoukos K, Andreadis C, Bozionelou V, Pistalmatzian N, Papatsoris A, Stravodimos K, Varthalitis I, Karamouzis M, Milaki G, Agorastos A, Kentepozidis N, Androulakis N, Bompolaki I, Kalofonos H, Mavroudis D, Dimopoulos MA.

Clin Genitourin Cancer. 2016 Apr;14(2):e153-9. doi: 10.1016/j.clgc.2015.09.009. Epub 2015 Sep 25.

PMID:
26437909
22.

A two staged treatment procedure for the difficult to treat bladder neck contractures with concomitant incontinence. In the search of a solution to a complex problem.

Adamakis I, Fragkiadis E, Katafigiotis I, Kousournas G, Stravodimos K, Constantinides CA.

Arch Ital Urol Androl. 2015 Sep 30;87(3):233-7. doi: 10.4081/aiua.2015.3.233.

23.

Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group.

Pistamaltzian N, Tzannis K, Pissanidou V, Peroukidis S, Milaki G, Karavasilis V, Mitsogiannis I, Varkarakis I, Papatsoris A, Dellis A, Adamakis I, Stravodimos K, Molyva D, Athanasiadis I, Androulakis N, Andreadis C, Kalofonos C, Mitropoulos D, Deliveliotis C, Constantinides C, Dimopoulos MA, Bamias A.

Anticancer Drugs. 2016 Jan;27(1):48-53. doi: 10.1097/CAD.0000000000000297.

24.

Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis.

Latosinska A, Vougas K, Makridakis M, Klein J, Mullen W, Abbas M, Stravodimos K, Katafigiotis I, Merseburger AS, Zoidakis J, Mischak H, Vlahou A, Jankowski V.

PLoS One. 2015 Sep 2;10(9):e0137048. doi: 10.1371/journal.pone.0137048. eCollection 2015. Erratum in: PLoS One. 2015;10(10):e0139268.

25.

Correcting and sharing our complications. Misplacement of pigtail catheter, during a Robot Assisted Pyeloplasty. Clinical findings, diagnosis, possible causes and endoscopic treatment.

Stravodimos K, Katafigiotis I, Fragkiadis E, Tyritzis S, Constantinides CA.

Arch Ital Urol Androl. 2015 Jul 7;87(2):165-6. doi: 10.4081/aiua.2015.2.165.

26.

Change of practice patterns in urology with the introduction of the Da Vinci surgical system: the Greek NHS experience in debt crisis era.

Deligiannis D, Anastasiou I, Mygdalis V, Fragkiadis E, Stravodimos K.

Arch Ital Urol Androl. 2015 Mar 31;87(1):56-61. doi: 10.4081/aiua.2015.1.56.

27.

Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment.

Avgeris M, Mavridis K, Tokas T, Stravodimos K, Fragoulis EG, Scorilas A.

Carcinogenesis. 2015 May;36(5):528-37. doi: 10.1093/carcin/bgv024. Epub 2015 Mar 24.

PMID:
25804644
28.

Distal ureterectomy techniques in laparoscopic and robot-assisted nephroureterectomy: Updated review.

Stravodimos KG, Komninos C, Kural AR, Constantinides C.

Urol Ann. 2015 Jan-Mar;7(1):8-16. doi: 10.4103/0974-7796.148575. Review.

29.

Detection of circulating tumor cells in bladder cancer using multiplex PCR assays.

Leotsakos I, Dimopoulos P, Gkioka E, Msaouel P, Nezos A, Stravodimos KG, Koutsilieris M, Constantinides CA.

Anticancer Res. 2014 Dec;34(12):7415-24.

PMID:
25503182
30.

Lithiasis of the renal allograft, a rare urological complication following renal transplantation: a single-center experience of 2,045 renal transplantations.

Mamarelis G, Vernadakis S, Moris D, Altanis N, Perdikouli M, Stravodimos K, Pappas P, Zavos G.

Transplant Proc. 2014 Nov;46(9):3203-5. doi: 10.1016/j.transproceed.2014.09.166.

PMID:
25420859
31.

A new tumor suppressor role for the Notch pathway in bladder cancer.

Rampias T, Vgenopoulou P, Avgeris M, Polyzos A, Stravodimos K, Valavanis C, Scorilas A, Klinakis A.

Nat Med. 2014 Oct;20(10):1199-205. doi: 10.1038/nm.3678. Epub 2014 Sep 7.

PMID:
25194568
32.

Sequential robot-assisted radical right nephrectomy and cholecystectomy: a safe combined procedure.

Spinoit AF, Stravodimos K, Nikiteas N, Ploumidis A, Lumen N, Ploumidis A.

Int J Med Robot. 2015 Jun;11(2):130-4. doi: 10.1002/rcs.1608. Epub 2014 Sep 2.

PMID:
25180492
33.
34.

Idiopathic spontaneous perforation of the upper urinary tract. A presentation of 4 cases.

Katafigiotis I, Adamakis I, Zormpala A, Pournaras C, Stravodimos K.

Arch Ital Urol Androl. 2014 Jun 30;86(2):142-3. doi: 10.4081/aiua.2014.2.142.

35.

Simultaneous laparoscopic management of ureteropelvic junction obstruction and renal lithiasis: the combined experience of two academic centers and review of the literature.

Stravodimos KG, Giannakopoulos S, Tyritzis SI, Alevizopoulos A, Papadoukakis S, Touloupidis S, Constantinides CA.

Res Rep Urol. 2014 May 20;6:43-50. doi: 10.2147/RRU.S59444. eCollection 2014.

36.

Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European multiinstitutional study.

Bamias A, Tzannis K, Papatsoris A, Oudard S, Beuselinck B, Escudier B, Liontos M, Elaidi TR, Chrisofos M, Stravodimos K, Anastasiou I, Mitropoulos D, Deliveliotis C, Constantinides C, Dimopoulos MA, Bamia C.

Clin Genitourin Cancer. 2014 Oct;12(5):373-83. doi: 10.1016/j.clgc.2014.03.012. Epub 2014 Mar 27.

PMID:
24819319
37.

The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma.

Stofas A, Levidou G, Piperi C, Adamopoulos C, Dalagiorgou G, Bamias A, Karadimou A, Lainakis GA, Papadoukakis S, Stravodimos K, Dimopoulos MA, Patsouris E, Gakiopoulou H, Korkolopoulou P.

BMC Cancer. 2014 Mar 4;14:149. doi: 10.1186/1471-2407-14-149.

38.

Differences in ureteroscopic stone treatment and outcomes for distal, mid-, proximal, or multiple ureteral locations: the Clinical Research Office of the Endourological Society ureteroscopy global study.

Perez Castro E, Osther PJ, Jinga V, Razvi H, Stravodimos KG, Parikh K, Kural AR, de la Rosette JJ; CROES Ureteroscopy Global Study Group.

Eur Urol. 2014 Jul;66(1):102-9. doi: 10.1016/j.eururo.2014.01.011. Epub 2014 Jan 23.

PMID:
24507782
39.

IMAC fractionation in combination with LC-MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkers.

Frantzi M, Zoidakis J, Papadopoulos T, Zürbig P, Katafigiotis I, Stravodimos K, Lazaris A, Giannopoulou I, Ploumidis A, Mischak H, Mullen W, Vlahou A.

J Proteome Res. 2013 Sep 6;12(9):3969-79. doi: 10.1021/pr400255h. Epub 2013 Aug 21.

PMID:
23924207
40.

A rare case of a 39 year old male with a parasite called Dioctophyma renale mimicking renal cancer at the computed tomography of the right kidney. A case report.

Katafigiotis I, Fragkiadis E, Pournaras C, Nonni A, Stravodimos KG.

Parasitol Int. 2013 Oct;62(5):459-60. doi: 10.1016/j.parint.2013.06.007. Epub 2013 Jun 28.

PMID:
23811203
41.

Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration.

Bamias A, Tzannis K, Beuselinck B, Oudard S, Escudier B, Diosynopoulos D, Papazisis K, Lang H, Wolter P, de Guillebon E, Stravodimos K, Chrisofos M, Fountzilas G, Elaidi RT, Dimopoulos MA, Bamia C.

Br J Cancer. 2013 Jul 23;109(2):332-41. doi: 10.1038/bjc.2013.341. Epub 2013 Jun 27.

42.

Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.

Foutadakis S, Avgeris M, Tokas T, Stravodimos K, Scorilas A.

Urol Oncol. 2014 Jan;32(1):39.e29-36. doi: 10.1016/j.urolonc.2013.04.005. Epub 2013 Jun 18.

PMID:
23790536
43.

The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients.

Avgeris M, Stravodimos K, Fragoulis EG, Scorilas A.

Br J Cancer. 2013 Jun 25;108(12):2573-81. doi: 10.1038/bjc.2013.250. Epub 2013 May 23.

44.

Quantified KLK15 gene expression levels discriminate prostate cancer from benign tumors and constitute a novel independent predictor of disease progression.

Mavridis K, Stravodimos K, Scorilas A.

Prostate. 2013 Aug;73(11):1191-201. doi: 10.1002/pros.22667. Epub 2013 Apr 26.

PMID:
23620432
45.

Low-grade fibromyxoid sarcoma of the renal pelvis: first report.

Alevizopoulos A, Mygdalis V, Tyritzis S, Stravodimos K, Constantinides CA.

Case Rep Nephrol Urol. 2012 Jul;2(2):87-91. doi: 10.1159/000341191. Epub 2012 Jul 10.

46.

Downregulation and prognostic performance of microRNA 224 expression in prostate cancer.

Mavridis K, Stravodimos K, Scorilas A.

Clin Chem. 2013 Jan;59(1):261-9. doi: 10.1373/clinchem.2012.191502. Epub 2012 Nov 7.

47.

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).

Bamias A, Dafni U, Karadimou A, Timotheadou E, Aravantinos G, Psyrri A, Xanthakis I, Tsiatas M, Koutoulidis V, Constantinidis C, Hatzimouratidis C, Samantas E, Visvikis A, Chrisophos M, Stravodimos K, Deliveliotis C, Eleftheraki A, Pectasides D, Fountzilas G, Dimopoulos MA.

Ann Oncol. 2013 Apr;24(4):1011-7. doi: 10.1093/annonc/mds583. Epub 2012 Nov 7.

PMID:
23136231
48.

Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.

Katafigiotis I, Tyritzis SI, Stravodimos KG, Alamanis C, Pavlakis K, Vlahou A, Makridakis M, Katafigioti A, Garbis SD, Constantinides CA.

BJU Int. 2012 Dec;110(11 Pt B):E688-93. doi: 10.1111/j.1464-410X.2012.11501.x. Epub 2012 Sep 28.

49.

L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer.

Koutalellis G, Stravodimos K, Avgeris M, Mavridis K, Scorilas A, Lazaris A, Constantinides C.

BJU Int. 2012 Sep;110(6 Pt B):E267-73. doi: 10.1111/j.1464-410X.2012.11152.x. Epub 2012 May 9.

50.

Radical cystectomy over the age of 75 is safe and increases survival.

Tyritzis SI, Anastasiou I, Stravodimos KG, Alevizopoulos A, Kollias A, Balangas A, Katafigiotis I, Leotsakos I, Mitropoulos D, Constantinides CA.

BMC Geriatr. 2012 Apr 30;12:18. doi: 10.1186/1471-2318-12-18.

Supplemental Content

Loading ...
Support Center